Press release
Antisense and RNAi Therapeutics Market worth $28.32 Billion by 2034, at a CAGR of 18.70%
The antisense and RNAi therapeutics market is witnessing a significant surge as biotechnology and genetic research evolve rapidly. These advanced therapeutics, leveraging gene silencing mechanisms, have shown tremendous promise in treating a variety of diseases, including genetic disorders, cancers, and neurodegenerative conditions. As the world moves toward precision medicine, the demand for targeted, less invasive treatment modalities is propelling the market forward.
In 2024, the global antisense and RNAi therapeutics market was valued at USD 5.10 billion. It is projected to grow at a robust CAGR of 18.70% during the forecast period of 2025-2034, ultimately reaching USD 28.32 billion by 2034. This growth is underpinned by increasing R&D investments, rising incidences of genetic disorders, and the expanding applications of RNA-based technologies.
Get a Free Sample Report with Table of Contents - https://h1.nu/1a2Zl.
Antisense and RNAi Therapeutics Market: A Detailed Report
Market Overview
Antisense and RNA interference (RNAi) therapies are gene-silencing technologies that work by inhibiting the expression of specific genes responsible for disease development. They represent a groundbreaking shift in the pharmaceutical landscape, offering highly specific therapeutic strategies with fewer off-target effects compared to traditional drugs.
Key drivers of this market include:
The growing prevalence of chronic and genetic diseases
Advancements in drug delivery technologies
Increasing collaborations and licensing agreements between biotech firms and pharmaceutical giants
Rising awareness and regulatory approvals for RNA-based therapies
Market Segmentation Insights
By Technology
RNA Interference (RNAi)
RNAi is a cellular mechanism that uses small RNA molecules to silence gene expression. The major RNAi technologies include:
siRNA (Small Interfering RNA): Targets specific mRNA for degradation, reducing protein production.
miRNA (MicroRNA): Regulates gene expression at the post-transcriptional level. Emerging as a key area for therapeutic intervention.
Antisense RNA
Antisense oligonucleotides (ASOs) are short, synthetic strands of DNA that bind to mRNA, inhibiting its translation into proteins. They have demonstrated success in treating genetic disorders like spinal muscular atrophy (SMA).
By Indication
Oncology
Cancer remains a prime focus for RNA-based therapies. siRNA and antisense molecules are being used to target oncogenes, inhibit tumor growth, and overcome drug resistance.
Cardiovascular Disease
RNA therapeutics are being explored to modulate cholesterol metabolism, inhibit inflammation, and reduce plaque buildup in cardiovascular patients.
Respiratory Disorders
Diseases like asthma, COPD, and pulmonary fibrosis are being targeted using inhaled RNA-based therapies for localized gene silencing.
Renal Disease
Antisense and RNAi treatments are being developed to target genes involved in nephropathy, polycystic kidney disease, and chronic kidney disorders.
Neurodegenerative Disorders
With diseases like Alzheimer's, Parkinson's, and Huntington's gaining attention, RNA therapies provide a promising option to silence genes responsible for neurotoxicity.
Genetic Disorders
Conditions like Duchenne muscular dystrophy (DMD), cystic fibrosis, and thalassemia are at the forefront of clinical trials for antisense and RNAi treatments.
Infectious Disease
RNAi therapies are also being studied for their potential to suppress viral replication in diseases like hepatitis B, HIV, and COVID-19.
Read the Full Report with the Table of Contents - https://h1.nu/1a2Zy.
By Route of Administration
Pulmonary Delivery: Ideal for respiratory and systemic diseases; enables direct lung targeting.
Intravenous Injections: Common route for delivering RNA-based therapies with fast systemic distribution.
Intra-dermal and Intraperitoneal Injections: Targeted delivery options for localized treatment.
Topical Delivery: Emerging method for dermatological and ophthalmic disorders.
Others: Includes oral and implantable delivery methods under early research.
By End User
Hospitals: Major revenue generator due to increased adoption of RNA therapies in clinical settings.
Specialty Clinics: Focused on niche indications and chronic disease management.
Others: Includes research organizations, CROs, and academic institutions.
By Region
North America
Dominates the global market, thanks to strong research infrastructure, early adoption of RNA therapeutics, and support from agencies like the FDA and NIH.
Europe
A strong biotech presence and regulatory push toward innovative medicines are driving European market growth.
Asia Pacific
Expected to witness the highest CAGR due to growing healthcare investments, rising awareness, and expansion of local biotech firms.
Latin America
A steadily growing market with increasing access to advanced therapies.
Middle East and Africa
Slow but emerging growth, particularly in countries investing in healthcare innovation.
Key Market Players
OliX Pharmaceuticals, Inc.
Sanofi S.A.
GlaxoSmithKline Plc
Ionis Pharmaceuticals, Inc.
Benitec Biopharma Inc.
Silence Therapeutics Plc
Astellas Pharma Inc.
Alnylam Pharmaceuticals, Inc.
MEDLINE Industries
Dicerna Pharmaceuticals
Tekmira Pharmaceuticals
Cenix BioScience
Sirnaomics
Arrowhead Pharmaceuticals
These companies are focusing on strategic partnerships, product innovation, and pipeline expansion to gain a competitive edge.
Emerging Trends and Opportunities
Personalized Medicine: RNA therapeutics allow for patient-specific treatment designs based on genetic profiles.
AI in RNA Drug Design: Integration of machine learning tools is accelerating RNA sequence optimization and delivery strategies.
Improved Delivery Platforms: The Development of lipid nanoparticles (LNPs) and viral vectors is enhancing therapeutic efficacy.
Expanded Indications: Beyond genetic diseases, RNA therapies are being explored for autoimmune diseases, metabolic disorders, and rare diseases.
Challenges Facing the Market
Delivery Limitations: Ensuring stability and targeted delivery remains a key concern.
High Development Costs: Long clinical trial phases and regulatory hurdles increase investment risks.
Safety Concerns: Off-target effects and immune reactions need to be managed.
Find More Reports
Acute Respiratory Syndrome Treatment Market - https://h1.nu/1a30r.
Neurorehabilitation Devices Market - https://h1.nu/15GkC.
Single-Use Bioreactor Market - https://h1.nu/1a30K.
Laparoscopy Devices Market - https://h1.nu/1a30O.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antisense and RNAi Therapeutics Market worth $28.32 Billion by 2034, at a CAGR of 18.70% here
News-ID: 4132923 • Views: …
More Releases from Expert Market Research
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and…
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions.
The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering…
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy.
Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial…
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview
The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
